Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

conjunctivitis: Inflammation of the conjunctiva of the eye. [ NCIT:P378 ]

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC S01GX
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector H7_USEOFEYEANTIALLERGENS

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 12606 9750 2856
Unadjusted prevalence (%) 4.85 6.63 2.53
Mean age at first event (years) 39.09 39.80 36.68

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.01 0.99 [0.76, 1.30] 9.5e-1 357
15 years 0.01 1.11 [0.87, 1.43] 3.9e-1 245
5 years 0.00 1.24 [0.90, 1.71] 1.8e-1 62
1 year - - - -

Correlations

Index endpoint: H7_USEOFEYEANTIALLERGENS – Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)
GWS hits: 7

Survival analyses between endpoints

Plot

before Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)
after Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)